Literature DB >> 22102098

Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken.

Kishan K Nyati1, Kashi N Prasad, Nagendra K Kharwar, Priyanka Soni, Nuzhat Husain, Vinita Agrawal, Arun K Jain.   

Abstract

Immunopathogenesis of Campylobacter jejuni-associated Guillain-Barré syndrome (GBS) is not yet well established probably due to lack of experimental model. Therefore, we studied the Th1/Th2 immune response and pathological changes in C. jejuni-induced chicken model for GBS. C. jejuni (5 × 10(9) CFU/ml) and placebo were fed to 30 chickens each. Stools of all birds were negative for C. jejuni by culture and PCR before experiment. The birds were regularly assessed for disease symptoms up to 30 days. Sciatic nerves from all chickens were examined at 5 days intervals by histopathology and immunohistochemistry, and also for the expression of Th1/Th2 cytokines. Twenty-two chickens (73.3%) developed diarrhea after C. jejuni infection; 18 (60.0%) experimental chickens developed GBS-like paralytic neuropathy. Pathology in the sciatic nerves of these chickens included perinodal and/or patchy demyelination, perivascular focal lymphocytic infiltration, myelin swelling and presence of macrophages within the nerve fibers on 10th-20th post-infection day (PID). Cytokines (IFN-γ, IL-1β, TNF-α, IL-6 and IL-2) were elevated in early phase (5th-15th PID) and TGF-β2, IL-10 and IL-4 in the recovery phase (25th-30th PID) of the disease. The study provides evidence that C. jejuni infection in the chicken can provide an experimental animal model of GBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102098     DOI: 10.1007/s00430-011-0220-3

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  40 in total

1.  A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review.

Authors:  M Honavar; J K Tharakan; R A Hughes; S Leibowitz; J B Winer
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

2.  Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Manuel Osorio; Dennis J Kopecko
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 3.  Mechanisms of Schwann cell damage in inflammatory neuropathy.

Authors:  C L Koski
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

4.  Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain-Barré syndrome.

Authors:  A Créange; L Bélec; B Clair; J C Raphaël; R K Gherardi
Journal:  J Neuroimmunol       Date:  1996-08       Impact factor: 3.478

5.  Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni.

Authors:  Michael A Jones; Sabine Tötemeyer; Duncan J Maskell; Clare E Bryant; Paul A Barrow
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  The Guillain-Barré syndrome: no longer a simple concept.

Authors:  P K Thomas
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

Review 7.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 8.  Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder.

Authors:  Nortina Shahrizaila; Nobuhiro Yuki
Journal:  J Biomed Biotechnol       Date:  2010-12-15

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

View more
  7 in total

Review 1.  Colonization properties of Campylobacter jejuni in chickens.

Authors:  C Pielsticker; G Glünder; S Rautenschlein
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-03-17

2.  Expression and significance of CD4(+)CD25(+)CD127(-) regulatory T cells in peripheral blood of patients with different phenotypes of Guillain-Barré syndrome.

Authors:  Hao Wang; Li Li; Yin Zhang; Shu-Chao Pan; An-Qiang Chen; Wei-Dong Qian
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10-/- BALB/c Mice Infected with a Guillain-Barré Syndrome-associated Campylobacter jejuni Strain.

Authors:  Jean M Brudvig; Matthew M Cluett; Elizabeth U Gensterblum-Miller; James Chen; Julia A Bell; Linda S Mansfield
Journal:  Comp Med       Date:  2022-03-10       Impact factor: 1.565

Review 4.  Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.

Authors:  Kishan Kumar Nyati; Roopanshi Nyati
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

Review 5.  Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.

Authors:  Kishan Kumar Nyati; Kashi Nath Prasad
Journal:  Mediators Inflamm       Date:  2014-09-22       Impact factor: 4.711

6.  The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.

Authors:  Hong Jiao; Huan Ren
Journal:  Drug Des Devel Ther       Date:  2018-11-06       Impact factor: 4.162

7.  The imbalance of Th1/Th2 triggers an inflammatory response in chicken spleens after ammonia exposure.

Authors:  Fuqing Zhao; Jianping Qu; Wei Wang; Shu Li; Shiwen Xu
Journal:  Poult Sci       Date:  2020-06-12       Impact factor: 3.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.